MBP and glaucoma: The global data were used to determine the discriminating power between control and glaucoma subjects, proposing the MBP, anti-SSA, anti-SSB, and anti-α-fodrin IgG/IgA as useful candidate biomarkers for diagnosis and clinical differentiation within groups.